TerrAscend Stock (CSE: TER) (OTCQX: TRSSF) - Investor Dashboard


➔ TerrAscend
CSE Ticker: TER
OTCQX Ticker: TRSSF
Sector: Healthcare
Industry: Legal Cannabis
Country: Canada
Employees: 20
Established: 2014
CEO: Dr. Michael Nashat

Summary

Fiscal Year-End: December
Facilities: 1
Dried Flower: Production and Sale
Extracts: Production
Number of Patients: N/A
Headquarters: Mississauga, ON

Financials (09/30/18)

Cash on hand: $15.1mm
Fixed Investment: $23.2 million
Shareholders’ Equity: $69.4 million
Revenues – Last Quarter: $1.8 million
Adj. Gross Margin : 4.5%
EPS : -0.03

Capital Structure (11/20/18)

Last Financing: 47.7 million units at $1.10
Basic Shares: 98.4 million
Warrants: 49.1 million
Options: 7.5 million
Diluted Shares: 155.1 million

Company Brief

TerrAscend is a biopharmaceutical and wellness company that is committed to quality products, brands and services for the global cannabinoid market.

TerrAscend strives to create and deliver quality products and services that meet the evolving needs of the cannabis market. The Company provides support to patients through its wholly-owned subsidiaries, TerrAscend Canada, a licensed producer of medical cannabis under the Access to Cannabis for Medical Purposes Regulations, and Solace Health Network Inc., a patient navigation and education platform led by health care professionals. The company also has a 50% stake in Solace Rx Inc., a drug preparation premises for non-cannabis formulations.

A Strong Growth Platform


Highlights

  • Strategic investors include Canopy Growth, Canopy Rivers, and JW Asset management
  • Licensed producer with significant processing, formulation and manufacturing capabilities
  • Management comprised of leaders from healthcare, pharmaceutical, banking and cannabis industries
  • Strong pharmaceutical and distribution expertise
  • 67,300 sq. ft. facility in Greater Toronto Area, nearby Pearson International Airport
  • Haven St. premium cannabis brand with 48 SKUs for the adult-use market in Canada

Growth Strategy

  • Focus on developing protectable intellectual property assets
  • Creating quality brands that resonate with patients and consumers
  • Ensure the highest standard of ethics and corporate responsibility
  • Invest in business streams that will utilize cannabinoids
  • Planned entrance into the U.S. market supported by an agreement with Canopy Growth and Canopy Rivers
  • Medical cannabis agreement with MCI Medical Clinics, which has 26 clinics and more than 2 million patients

Differentiators

  • Pursuing U.S. cannabis markets
  • Focused on creating differentiated products for the global cannabinoid market
  • Experienced team with deep ties to global pharmaceutical distribution
  • Developing drug preparation premises for non-cannabinoid formulations
  • Leverage proximity to Toronto to distribute on behalf of third-party LPs, with same-day delivery capabilities
  • Supply agreements with Ontario, British Columbia, Nova Scotia, and Prince Edward Island

The Four Pillars of TerrAscend

TerrAscend operates complementary business units that leverage its location, personnel, and strategic vision, providing a uniquely holistic business offering. TerrAscend believes that the cannabis space is much broader that just cultivating the crop, and as such, the company is working with strategic partners to develop businesses that complement the cannabis plant.

Advancing Research
  • Emphasis on developing protectible intellectual property
  • Advancing plant genetics and product formulations
  • Pharma-grade manufacturing facility
Building Brands
  • Developing trusted and recognized brands
  • Addressing needs of multiple cannabis business streams
  • Defining brands based on deep consumer insights
Promoting Responsibility
  • Ensuring highest standard of ethics and corporate integrity
  • Advocating responsible use of products
  • Exceeding industry and regulatory standards
Optimizing Wellness
  • Providing support for medical cannabis use
  • Guiding cannabis selection and consumption preferences
  • Enhancing the therapeutic application of cannabinoids

Curated Stories & News


Visit TerrAscend, Inc.
at www.terrascend.com.

New Cannabis Ventures in partnership with due diligence platform 420Investor, is the definitive source for fact-based, data-driven, financial information and relevant company news for qualified publicly traded cannabis companies. NCV extracts and parses only the most important content. Information is provided “as is” and solely for informational purposes, not for trading or advice. TerrAscend, Inc. is a client of NCV Media, LLC. Read our full disclaimer.